Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Hung

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|July 8, 2003
Transcriptional targeting of the HER-2/neu oncogeneS C Wang, M C Hung
Molecular and Cellular Biology|December 1, 1990
Multiple cis- and trans-acting elements involved in regulation of the neu geneT C Suen, M C Hung
Molecular and Cellular Biology|April 1, 1991
Identification and characterization of a novel enhancer for the rat neu promoterD H Yan, M C Hung
Oncogene|November 1, 1991
Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cellsD H Yu, M C Hung
Breast Disease|February 3, 2005
Suppressing HER2/neu-mediated cell transformation by transcriptional repressorsM C Hung, S C Wang
The Journal of Biological Chemistry|August 25, 1993
Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogeneD B Reardon, M C Hung
British Journal of Cancer|January 26, 2006
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survivalH-W Lo, M-C Hung
Oncogene|April 1, 1992
Cloning and characterization of the mouse neu promoterM R White, M C Hung
British Journal of Cancer|December 22, 2011
The role of EZH2 in tumour progressionC-J Chang, M-C Hung
Seminars in Oncology|November 14, 2001
HER2 overexpression and cancer targetingS C Wang, M C Hung
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Drugs of Today (Barcelona, Spain : 1998)|July 8, 2003
Transcriptional targeting of the HER-2/neu oncogeneS C Wang, M C Hung
Molecular and Cellular Biology|December 1, 1990
Multiple cis- and trans-acting elements involved in regulation of the neu geneT C Suen, M C Hung
Molecular and Cellular Biology|April 1, 1991
Identification and characterization of a novel enhancer for the rat neu promoterD H Yan, M C Hung
Oncogene|November 1, 1991
Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cellsD H Yu, M C Hung
Breast Disease|February 3, 2005
Suppressing HER2/neu-mediated cell transformation by transcriptional repressorsM C Hung, S C Wang
The Journal of Biological Chemistry|August 25, 1993
Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogeneD B Reardon, M C Hung
British Journal of Cancer|January 26, 2006
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survivalH-W Lo, M-C Hung
Oncogene|April 1, 1992
Cloning and characterization of the mouse neu promoterM R White, M C Hung
British Journal of Cancer|December 22, 2011
The role of EZH2 in tumour progressionC-J Chang, M-C Hung
Seminars in Oncology|November 14, 2001
HER2 overexpression and cancer targetingS C Wang, M C Hung
Pageof 21